Hong Kong Biotech Stock News

SEHK:2357
SEHK:2357Aerospace & Defense

AviChina Industry & Technology (SEHK:2357) Margin Compression Challenges Bullish EPS Growth Narrative

AviChina Industry & Technology (SEHK:2357) opened FY 2025 with first half revenue of C¥37.5b and basic EPS of C¥0.129, setting the tone for how the rest of the year might shape up for shareholders watching earnings closely. The company has seen revenue move from C¥33.6b in 1H 2024 to C¥53.4b in 2H 2024 and then to C¥37.5b in 1H 2025, while basic EPS shifted from C¥0.157 to C¥0.117 and now C¥0.129. This puts more focus on how efficiently each yuan of sales is turning into profit and how that...
SEHK:358
SEHK:358Metals and Mining

Jiangxi Copper (SEHK:358) Thin 1.3% Margin Tests Bullish Earnings Growth Narrative

Jiangxi Copper (SEHK:358) has wrapped up FY 2025 with fourth quarter revenue of CN¥148.6b and basic EPS of CN¥0.33. Trailing 12 month revenue sits at CN¥544.6b with EPS of CN¥2.07. Over recent periods, the company has reported quarterly revenue ranging from CN¥111.6b to CN¥148.6b and basic EPS between CN¥0.33 and CN¥0.64. This gives investors a clearer view of how top line scale and per share earnings have tracked through the year. With trailing net margins around 1.3% after a large one off...
SEHK:1070
SEHK:1070Consumer Durables

TCL Electronics (SEHK:1070) Earnings Jump And Thin Margins Test Bullish Platform Narratives

TCL Electronics Holdings (SEHK:1070) has released fresh numbers for FY 2025, with first half revenue of HK$54.8b and basic EPS of HK$0.45 providing the latest view on profitability. Over recent periods, the company’s revenue has moved from HK$45.5b in 1H 2024 to HK$53.8b in 2H 2024 and HK$54.8b in 1H 2025, while basic EPS shifted from HK$0.27 to HK$0.46 and then HK$0.45. This gives investors a clearer picture of how top line scale and per share earnings are tracking into a net margin that...
SEHK:1126
SEHK:1126Leisure

Dream International (SEHK:1126) Margin Compression Reinforces Bearish Manufacturing Narratives

Dream International (SEHK:1126) has posted its FY 2025 first half results with revenue of HK$2.6b and basic EPS of HK$0.45, setting the tone for how you might reassess the story around the stock. The company has seen revenue move from HK$2.3b in 1H 2024 to HK$3.2b in 2H 2024 and then to HK$2.6b in 1H 2025, while EPS shifted from HK$0.41 to HK$0.68 and then to HK$0.45 over the same periods, putting the latest figures in clear context. With net margins easing over the last year, the focus now...
SEHK:1274
SEHK:1274Auto Components

IMotion Automotive Technology Suzhou SEHK 1274 Losses Persist Challenging Revenue Growth Narrative

Latest earnings snapshot iMotion Automotive Technology (Suzhou) (SEHK:1274) has posted its FY 2025 first half numbers with revenue of C¥366 million and a basic EPS loss of C¥0.75, setting the tone against a current share price of C¥3.17. The company has seen revenue move from C¥636 million in 1H 2024 to C¥612 million in 2H 2024 and then to C¥366 million in 1H 2025. Over the same periods, basic EPS moved from a loss of C¥0.44 to a loss of C¥0.84 and then to a loss of C¥0.75, leaving investors...
SEHK:6098
SEHK:6098Real Estate

Country Garden Services Holdings (SEHK:6098) Margin Compression Challenges Bullish Earnings Recovery Narrative

Country Garden Services Holdings (SEHK:6098) has reported its FY 2025 first half results with revenue of CN¥23.2b and basic EPS of CN¥0.30, setting the stage against a trailing twelve month picture of CN¥48.4b in revenue and EPS of CN¥0.18 alongside net income of CN¥601.5m. Over recent periods, the company has seen revenue move from CN¥21.0b in 1H 2024 to CN¥23.2b in 1H 2025. Basic EPS shifted from CN¥0.43 in 1H 2024 and CN¥0.11 in 2H 2024 to CN¥0.30 in the latest half, leaving investors to...
SEHK:1681
SEHK:1681Pharmaceuticals

Consun Pharmaceutical Group (SEHK:1681) Earnings Growth And 31.5% Margins Challenge Valuation Skeptics

Consun Pharmaceutical Group (SEHK:1681) opened FY 2025 with first half revenue of C¥1.57b and basic EPS of C¥0.59, set against trailing twelve month revenue of C¥3.42b and EPS of C¥1.27 that reflect earnings growth of 18.4% over the past year. The company has seen revenue move from C¥2.97b to C¥3.42b on a trailing basis, while EPS has gone from C¥1.11 to C¥1.27, supported by a trailing net profit margin of 31.5% that edges above last year’s 30.7%. This keeps profitability squarely in focus...
SEHK:1099
SEHK:1099Healthcare

A Look At Sinopharm Group (SEHK:1099) Valuation After The Proposed 2025 Final Dividend Announcement

Sinopharm Group (SEHK:1099) has drawn investor attention after its board proposed a final dividend of CN¥0.69 per share for 2025, totaling about CN¥2.15b, subject to approval at the June 18 AGM. See our latest analysis for Sinopharm Group. The proposed dividend comes after a period where momentum has been mixed, with a 30 day share price return showing a decline of 7.38% and a one year total shareholder return of 15.09%. This suggests recent weakness against a stronger longer term outcome. If...
SEHK:86
SEHK:86Consumer Finance

Assessing Sun Hung Kai (SEHK:86) Valuation After Strong 2025 Earnings And Higher Dividend

Sun Hung Kai (SEHK:86) has drawn fresh attention after reporting full year 2025 results, with revenue of HK$5,473.6 million, net income of HK$1,593.1 million and a higher total dividend compared with 2024. See our latest analysis for Sun Hung Kai. At a share price of HK$4.25, Sun Hung Kai has seen a 6.52% 90 day share price return and a 45.33% 1 year total shareholder return, which may indicate momentum around the stronger earnings and higher dividend announcement. If the earnings story here...
SEHK:9926
SEHK:9926Biotechs

Akeso (SEHK:9926) FY 2025 Loss Deepens Despite 2H Revenue Growth Challenging Bullish Narratives

Akeso (SEHK:9926) has reported FY 2025 results with second half revenue of C¥1.6b and a basic EPS loss of C¥0.60, while trailing 12 month revenue reached C¥3.1b against a net loss of C¥1.1b. The business has seen revenue move from C¥1.1b in 2H 2024 to C¥1.6b in 2H 2025, with basic EPS shifting from a loss of C¥0.32 to a loss of C¥0.60 over the same period, as investors weigh growth in the top line against persistent losses. Overall, the latest numbers point to expanding operations but...
SEHK:1357
SEHK:1357Interactive Media and Services

Meitu (SEHK:1357) Net Margin Jump To 25.4% Tests Bullish AI Earnings Narrative

Meitu (SEHK:1357) has just posted its FY 2025 first half scorecard, with revenue of CN¥1.8b and basic EPS of CN¥0.09, against a backdrop of trailing twelve month revenue of CN¥3.5b and EPS of CN¥0.20 that coincides with earnings growth of 97.9% over the past year. The company has seen revenue move from CN¥1.6b and EPS of CN¥0.07 in 1H 2024 to CN¥1.8b and EPS of CN¥0.09 in 1H 2025, while trailing net profit margin sits at 25.4% versus 14.9% a year earlier and sets up a margin story that...
SEHK:517
SEHK:517Infrastructure

A Look At COSCO SHIPPING International (Hong Kong) (SEHK:517) Valuation After Its Latest Full Year Earnings Results

COSCO SHIPPING International (Hong Kong) (SEHK:517) released full year 2025 results, reporting sales of HK$3,705.73 million and net income of HK$771.06 million, along with higher basic and diluted earnings per share compared with the prior year. See our latest analysis for COSCO SHIPPING International (Hong Kong). The full year results come after a mixed price stretch, with a 1 day share price return of 2.84% and a 30 day share price return showing a decline of 17.07%, while the 1 year total...
SEHK:2367
SEHK:2367Personal Products

Giant Biogene Holding SEHK 2367 Valuation Check After Weaker Earnings And Adjusted Dividends

Giant Biogene Holding (SEHK:2367) released full year 2025 results, reporting revenue and net income below the prior year. The company also proposed a reduced final ordinary dividend alongside a separate special dividend for shareholders. See our latest analysis for Giant Biogene Holding. Despite the latest earnings release and the mix of a reduced ordinary dividend with a separate special dividend, Giant Biogene Holding’s 1-year total shareholder return of 56.34% decline and 3-year total...
SEHK:3690
SEHK:3690Hospitality

Meituan (SEHK:3690) Posts C¥23.4b TTM Loss Testing Bullish Profitability Narratives

Meituan (SEHK:3690) has just wrapped up FY 2025 with fourth quarter revenue of about C¥90.97b and a net loss of roughly C¥15.14b, while the latest trailing twelve month figures show revenue of around C¥364.85b and a net loss of about C¥23.36b, translating to a TTM EPS of C¥3.84. Over recent periods the company has seen quarterly revenue move between roughly C¥86.56b and C¥95.49b, with net income ranging from a profit of about C¥10.06b in Q1 2025 to losses of C¥18.63b in Q3 2025. As a result,...
SEHK:240
SEHK:240Construction

Build King Holdings (SEHK:240) Margins Edge Up To 3.3% Reinforcing Gradual Earnings Growth Narrative

Build King Holdings (SEHK:240) has released its FY 2025 figures with first half revenue of HK$6.9b and basic EPS of HK$0.14, set against trailing twelve month revenue of HK$13.8b and EPS of HK$0.37 that reflect 4.3% earnings growth over the past year. Over the last three reported half year periods, revenue has moved from HK$6.5b in 1H 2024 to HK$7.9b in 2H 2024 and HK$6.9b in 1H 2025, while basic EPS has tracked from HK$0.12 to HK$0.23 and then HK$0.14, giving investors a clearer read on...
SEHK:546
SEHK:546Chemicals

Fufeng Group (SEHK:546) Net Margin Strength Reinforces Bullish Profitability Narratives

Fufeng Group (SEHK:546) has put fresh numbers on the table for FY 2025, with first half revenue of C¥13.96b and basic EPS of C¥0.71 setting the tone for its latest update. Over the last three reported halves, revenue has moved from C¥13.37b in 1H 2024 to C¥14.39b in 2H 2024 and C¥13.96b in 1H 2025, while basic EPS has shifted from C¥0.41 to C¥0.51 and then to C¥0.71, giving you a clear view of how the top and bottom lines are tracking through the cycle. Taken together with trailing twelve...
SEHK:2669
SEHK:2669Real Estate

China Overseas Property Holdings (SEHK:2669) Margin Decline Challenges Bullish Growth Narratives

China Overseas Property Holdings (SEHK:2669) has just posted its FY 2025 first half numbers, with revenue at about C¥7.1b and basic EPS of C¥0.23. This sets a clear marker for where the business stands today. Over the past three reported halves, revenue has moved from C¥6.8b in 1H 2024 to C¥7.2b in 2H 2024 and C¥7.1b in 1H 2025. Basic EPS has tracked from C¥0.22 to C¥0.24 and now C¥0.23, giving a straightforward view of how the top and bottom line are trending into the latest report. With net...